Rearranged during transfection protooncogene - CISMeF
Rearranged during transfection protooncogeneOMIM Phenotype
Preferred Label : Rearranged during transfection protooncogene;
Obsolete resource : true;
Alternative titles and symbols : Ret; Ret protooncogeneret/elks fusion gene; Hirschsprung disease, protection against;
Description : The RET protooncogene is one of the receptor tyrosine kinases, cell-surface molecules
that transduce signals for cell growth and differentiation. The RET gene was defined
as an oncogene by a classical transfection assay. RET can undergo oncogenic activation
in vivo and in vitro by cytogenetic rearrangement (Grieco et al., 1990). Mutations
in the RET gene are associated with multiple endocrine neoplasia, type IIA (MEN2A;
171400), multiple endocrine neoplasia, type IIB (MEN2B; 162300), Hirschsprung disease
(HSCR; aganglionic megacolon; 142623), and medullary thyroid carcinoma (MTC; 155240).
Plaza-Menacho et al. (2006) reviewed the genetics and molecular mechanisms underlying
the different inherited neural crest-related disorders involving RET dysfunction.;